We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Patient Page |

Hepatitis B FREE

Janet M. Torpy, MD, Writer; Alison E. Burke, MA, Illustrator; Robert M. Golub, MD, Editor
JAMA. 2011;305(14):1500. doi:10.1001/jama.305.14.1500.
Text Size: A A A
Published online

Hepatitis B is a viral infection of the liver. Along with other hepatitis types (such as hepatitis C and hepatitis E), hepatitis B is caused by transmission (spread) of the virus through blood and body fluids. Some persons infected with hepatitis B develop a chronic infection, become carriers, and are then able to pass on the infection to others. All individuals with hepatitis B are at higher risk of developing liver cancer and cirrhosis of the liver. Hepatitis A is a less serious type of viral liver infection that is transmitted by the fecal-oral route (by contaminated water, food, surfaces, and hands). Hepatitis B affects more than 300 million individuals worldwide and is a serious health problem in many industrialized nations and developing countries. Most people who have chronic hepatitis B were infected at birth or in early childhood. The April 13, 2011, issue of JAMA includes an article about hepatitis B vaccine.


  • Intravenous illegal drug use, especially if reusing or sharing needles

  • Unprotected sexual activity

  • Blood product transfusion (the risk of contracting hepatitis B from a blood transfusion is low, approximately 1 in 200 000 units)

  • Newborn infants can be infected with hepatitis B at delivery if their mother carries the virus.

  • Exposure to blood at your job (such as health care and public safety workers)

  • Persons receiving hemodialysis for severe kidney disease

  • Body piercing, tattooing

  • Medical tourism


Most cases of acute hepatitis B resolve on their own, do not require treatment, and result in lifelong immunity. Supportive care for patients with acute illness includes rest and fluids for hydration. For individuals with a known exposure to hepatitis B, rapid treatment with hepatitis B immune globulin (HBIG) and the hepatitis B vaccine can prevent actual infection. Chronic hepatitis B infection may or may not require treatment, but patients should be monitored by a physician who has experience treating chronic hepatitis.


  • Vaccination can reduce the likelihood of hepatitis B infection. The vaccine is given in a series of 3 to 4 injections during a 6-month period.

  • Immunizing individuals of any age, including infants, is safe and effective. Infants should receive their first dose of vaccine at birth. Immunization is recommended for children and teens who have not been previously vaccinated.

  • Persons who travel extensively in areas of the world where hepatitis B is common should consider having the vaccine, as should anyone in close contact with a patient who has hepatitis B.

  • Anyone belonging to one of the high-risk groups, including health care workers, dialysis patients, persons who abuse intravenous drugs, and those who participate in unprotected sexual activity (heterosexual or homosexual), should receive the hepatitis B vaccine.

  • Any individual who wants protection against hepatitis B should discuss the vaccine with his or her doctor.



To find this and previous JAMA Patient Pages, go to the Patient Page Index on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A Patient Page on hepatitis C was published in the February 21, 2007, issue; one on hepatitis A virus was published in the July 13, 2005, issue; one on blood donation was published in the May 21, 2008, issue; and one on liver transplantation was published in the May 10, 2006, issue.

Centers for Disease Control and Prevention; National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases; American Red Cross; Hepatitis Foundation International; National Center for Biotechnology Information

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Spanish Patient Pages
Supplemental Content

Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles